ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 146 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,888,652 | +4.7% | 288,801 | +2.1% | 0.02% | 0.0% |
| Q2 2023 | $5,621,899 | +29.3% | 282,934 | +11.5% | 0.02% | +21.4% |
| Q1 2023 | $4,347,782 | -11.7% | 253,811 | +0.8% | 0.01% | -12.5% |
| Q4 2022 | $4,925,730 | -10.3% | 251,698 | -35.6% | 0.02% | -20.0% |
| Q3 2022 | $5,489,000 | +13.6% | 390,930 | +5.4% | 0.02% | +17.6% |
| Q2 2022 | $4,831,000 | +47.0% | 370,749 | +79.0% | 0.02% | +88.9% |
| Q1 2022 | $3,286,000 | -22.0% | 207,174 | +7.4% | 0.01% | 0.0% |
| Q4 2021 | $4,212,000 | +44.9% | 192,929 | +98.4% | 0.01% | +28.6% |
| Q3 2021 | $2,907,000 | -32.2% | 97,265 | +0.5% | 0.01% | -36.4% |
| Q2 2021 | $4,287,000 | +3.9% | 96,801 | +4.1% | 0.01% | 0.0% |
| Q1 2021 | $4,126,000 | -20.9% | 92,990 | -2.3% | 0.01% | -21.4% |
| Q4 2020 | $5,217,000 | – | 95,135 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |